B3: date of implant estimated as (b)(6) 2023.D4: the udi is unknown because the part/lot numbers were not provided.The device was not returned for analysis.A review of the lot history record and similar incident review of the reported lot could not be conducted because the part and lot numbers were not provided.The investigation determined a conclusive cause for the reported stretched-stent, the reported patient-device incompatibility-recoil and the reported defective device-shortened cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.The reported adverse patient effects referenced in b5 are being filed under a separate medwatch report #.Attachment: article titled, 'a systematic review and meta-analysis of supera interwoven nitinol stents for the treatment of infrainguinal peripheral arterial disease'na.
|
It was reported through a research article identifying supera that may be related to the following: stenosis, occlusion, dissection, elongation, compression, malapposition, invagination, and amputation.This is a systematic review for articles published from december 2011 up to may 2021 regarding studies assessing the safety and efficacy of supera interwoven nitinol stent for the treatment of infra-inguinal peripheral artery disease.Details are in the attached article titled, "a systematic review and meta-analysis of supera interwoven nitinol stents for the treatment of infrainguinal peripheral arterial disease".
|